Cytovale
ID: 5877172Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.
4
Funding Rounds
$203.3m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Aj** Sh** |
|
- | - |
| He*** Ts* | - | - | - |
| Ma** Ma******* |
|
- |
Funding series
Funding Series Analysis
The company Cytovale has raised a total of $100m in funding over 4 rounds.
Key Insights:
- Cytovale October 2024 Series D Funding Round: $100m
- Cytovale Series B round, October 2019: $15m
- CytoVale Series C round, November 15, 2023: $84m
- CytoVale Series A round, June 10, 2014: $4.3m
Industries
Cytovale is active in the following industries: